Sunday, January 25, 2026

Latest

Microsoft: BMO Raises Price Target To $325 After Strong Earnings

Earlier this week, Microsoft (NASDAQ: MSFT) reported its fiscal fourth-quarter results. The company reported $46.15 billion in top-line revenue, smashing even the highest analyst estimate. Microsoft grew revenues at 21.3% year over year while their gross profit grew 25.2% year over year to $32.161 billion. Gross margin came in at 69.7% while operating margin came in at 41.4%. Net income grew to $16.45 billion or $2.17 in earnings per share.

Many analysts raised their 12-month price target on Microsoft after the results, bringing their 12-month price target up to $322.54 up from the $306.13 consensus before earnings. The street high sits at $378 while the lowest target comes in at $256.70. 40 analysts currently cover the company, of which 18 analysts have strong buy ratings, 20 have buy and two have hold ratings.

BMO Capital Markets was one of the analysts who raised their 12-month price target on Microsoft, raising it to $325 from $290 while also reiterating their outperform rating.

Microsoft beat all of BMO’s estimates for the quarter. The company reported stronger PBP revenues while LinkedIn growth came in very robust with the help of a “much better macro and advertising business” driving most of the increase.

For Microsoft’s Azure segment, BMO says that the growth was fairly modest at 51% year over year but the guidance made up for the growth. Their guidance implies a 45% increase year over year in Azure revenue which is 5% higher than the 40% expected growth.

Below you can see BMO’s updated first quarter, 2022, and 2023 estimates.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Moon River Moly: The Davidson Moly-Copper-Tungsten PEA

Integra: The DeLamar Heap Leach Feasibility Study

Highlander Silver: The Saviour Of Bear Creek Mining

Recommended

Stifel Reiterates BUY On Goliath Resources After Surebet Drill Results

Steadright Subsidiary NSM Capital Sarl Applies For License At Titanbeach One

Related News

Columbia Care: Canaccord Reiterates Top Pick Following Green Leaf Medical Acquisition

Last Friday, Columbia Care Inc. (CSE: CCHW) closed their acquisition of Green Leaf Medical which...

Friday, June 18, 2021, 01:30:00 PM

Cybin: Canaccord Bumps Price Target To US$7.00

Cybin Inc (NEO: CYBN) last month had a long month of news reports, the first...

Thursday, September 2, 2021, 11:16:00 AM

Docusign: Analysts Anticipate $437.8 Million In Q1 Revenues

Docusign (NASDAQ: DOCU) will be reporting their first quarter 2022 financial results today after market...

Thursday, June 3, 2021, 11:15:00 AM

Hexo: Canaccord Raises Price Target To $9.50

On March 18th, Hexo Corp (TSX: HEXO) (NYSE: HEXO) reported their fiscal second quarter results....

Sunday, March 21, 2021, 02:29:00 PM

Aurora: Canaccord Raises Price Target To $14.00 On Back Of Earnings

Last night, Aurora Cannabis (TSX: ACB) (NYSE: ACB) reported its second quarter 2020 earnings. They...

Friday, February 12, 2021, 04:02:00 PM